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MicroRNAs are important regulators of gene expres-
sion and associated with stress-related psychiatric
disorders. Here, we report that exposing mice
to chronic stress led to a specific increase in
microRNA-15a levels in the amygdala-Ago2 complex
and a concomitant reduction in the levels of its pre-
dicted target, FKBP51, which is implicated in
stress-related psychiatric disorders. Reciprocally,
mice expressing reduced levels of amygdalar
microRNA-15a following exposure to chronic stress
exhibited increased anxiety-like behaviors. In hu-
mans, pharmacological activation of the glucocorti-
coid receptor, as well as exposure to childhood
trauma, was associated with increased microRNA-
15a levels in peripheral blood. Taken together, our
results support an important role for microRNA-
15a in stress adaptation and the pathogenesis of
stress-related psychopathologies.INTRODUCTION
Recent studies have linked microRNA (miRNA) expression
or biogenesis dysregulation to various psychiatric disorders,
including anxiety and depression (Dias et al., 2014b; Issler and
Chen, 2015; Issler et al., 2014; Lopez et al., 2014; O’Connor
et al., 2012; Volk et al., 2014). However, changes in miRNA
expression levels do not necessarily reflect their immediate
activity; it is only when a specific miRNA, in the canonical
pathway, has matured and been incorporated into the RNA-
induced silencing complex (RISC) in the presence of argonaute
RISC catalytic component 2 (Ago2) that it becomes truly active
(Meister et al., 2004) as a result of its association with its target
mRNA.
The amygdala plays a pivotal role in regulating the behavioral
responses to stressful challenges (Dunsmoor and Paz, 2015; Du-1882 Cell Reports 17, 1882–1891, November 8, 2016 ª 2016 The Au
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2014; Maren and Holmes, 2016). Recently, regulation of some
amygdalar functions and stress-related behaviors has been
attributed to miRNAs. miR-34c is involved in regulating stress-
induced anxiety (Haramati et al., 2011) and miR-34a in fear
memory consolidation (Dias et al., 2014a). Furthermore, miR-
19b plays an important role in memory consolidation following
stress by regulating the adrenergic receptor beta 1 (Volk et al.,
2014).
In this study, we investigated Ago2-associated miRNAs and
transcripts in the amygdala of mice subjected to a chronic social
defeat stress. This chronic social stress paradigm consists of 10
consecutive days of short physical encounters between a
C57BL/6 mouse and an aggressive ICR (CD1) mouse (Golden
et al., 2011; Krishnan et al., 2007). The repeated exposure to
stress is considered a model for the induction of chronic stress
(Elliott et al., 2010, 2016; Issler et al., 2014), as well as depres-
sion-like behavior (Hollis and Kabbaj, 2014; Malatynska and
Knapp, 2005) in mice. Molecular analysis and behavioral studies
demonstrate that miR-15a is recruited to the Ago2 complex
following chronic stress and is an essential regulator of an intact
behavioral response to chronic stress.
RESULTS
miR-15a and FKBP51mRNAAreAssociatedwith Ago2 in
the Amygdala following Chronic Stress
To identify miRNAs that are involved in the regulation of the
behavioral response to chronically stressful challenges, we
immunoprecipitated the Ago2 complex in tissue obtained from
the amygdala of mice 8 days after completion of the chronic so-
cial defeat stress. Mice were subjected to the chronic social
defeat stress paradigm for 10 consecutive days (Figure 1A),
following which they were subjected to a social avoidance test
to categorize them as being either ‘‘susceptible’’ or ‘‘resilient’’
to the chronic social defeat stress (Figure 1B). The RNA from
the Ago2 complex of three groups—susceptible, resilient, and
control—was extracted and analyzed in parallel using two
distinct microarray platforms; a miRNA and a mRNA expressionthors.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. miR-15a Is Elevated following Chronic Stress and Potentially Regulates FKBP51
(A) Schematic illustration of the social defeat paradigm. C57 mice are subjected to 5 min of physical contact (left) with an aggressive ICR mouse, followed by
sensory contact for 24 hr (right).
(B) Social avoidance test. Unstressed mice spend more time in the interaction zone following introduction of an unfamiliar mouse, t(16) = 3.657, p = 0.002.
Susceptible mice spend less time in the interaction zone following introduction of an unfamiliar mouse, t(16) = 3.133, p = 0.006. Resilient mice spendmore time in
the interaction zone following introduction of an unfamiliar mouse, t(16) = 2.358, p = 0.031. Data are represented as mean ± SEM.
(C) Extracts of the amygdalae ofmice subjected to social defeat were used for immunoprecipitation (IP) with anti-Ago2 antibody. The bound RNAwas analyzed on
a miRNA array (four control arrays, n = 12 animals; six social defeat arrays, n = 18 animals) and a gene expression array (three control arrays, n = 9 animals; six
social defeat arrays, n = 18 animals).
(D) Log2 miRNA expression analysis. Four miRNAs were elevated, and ten miRNAs were decreased in the amygdala Ago2 complex following social defeat.
(E) miR-15a levels were elevated in the Ago2 precipitate, t(7) = 7.147, p = 0.0002; as was FKBP51 mRNA, t(7) = 5.352, p = 0.0011.
(F) miR-15a was also elevated in total RNA extracted from mice amygdalae (n = 5) following social defeat, t(8) = 2.46, p = 0.039; whereas FKBP51 levels (n = 5)
were decreased, t(8) = 3.531, p = 0.008. Data are represented as mean ± SEM.
(G) FKBP51 protein levels following social defeat. FKBP51 protein levels are downregulated in chronically stressed mice compared to control, t(6) = 3.049, p =
0.014. Data are represented as mean ± SEM.
Error bars represent mean ± SEM. *p < 0.05; **p < 0.01.
See also Figures S1 and S2.
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Figure 2. miR-15a and miR-16-1 Are Differentially Expressed
following Chronic Stress
(A) Schematic illustration of the miR-15a and miR-16-1 transcript.
(B) Alignment of the mature sequence of miR-15a and miR-16.
(C) The distribution of miR-15a and miR-16 in different brain regions. Olf., ol-
factory; PFC, prefrontal cortex.
(D) Comparison of the amygdala Ago2 IP results of miR-15a and miR-16. Data
are represented as mean ± SEM. **p < 0.01.array (Figure 1C). Initially, we hypothesized that we would
observe changes in the miRNA population of the Ago2 complex
in the amygdala not only between stressed and control mice but
also between susceptible and resilient mice. However, our anal-
ysis revealed that no significant changeswere detected between
the susceptible and resilient mice. For this reason, we combined
the two groups of mice into one that is referred to in the text as
‘‘social defeat.’’ Analysis of the miRNA array revealed four
miRNAs that were upregulated and ten that were downregulated
(Figure 1D; Figure S1A). A parallel analysis on the gene array re-
vealed a small number of mRNAs that were either upregulated or1884 Cell Reports 17, 1882–1891, November 8, 2016downregulated in the Ago2 complex immunoprecipitation (IP)
following social defeat (Figure S1B). When we analyzed the
mRNAs that were changed following social defeat, we focused
on stress-associated genes that were previously described to
be expressed in the amygdala. This is the reason we focused
on FK506 binding protein 51 (FKBP51) and miR-15a. FKBP51
has been previously linked to the pathogenesis of posttrau-
matic stress disorder and depression (Binder et al., 2008;
Klengel et al., 2013; Lekman et al., 2008; Zannas et al.,
2016). miR-15a levels were raised 1.8-fold (p = 0.0002) in the
array following exposure to chronic stress (Figure 1E). Interest-
ingly, a parallel increase in FKBP51 mRNA (p = 0.001), a pre-
dicted target of miR-15a, was observed in the Ago2 complex
(Figure 1E). Whereas the levels of miR-15a were also elevated
(p = 0.039) in the total RNA levels of the amygdala tissue,
FKBP51 levels were, as expected, decreased (p = 0.008)
(Figure 1F), supporting the possibility that FKBP51 is directly
downregulated by miR-15a in the amygdala. Consistently, the
protein levels of FKBP51 were measured, and a reduction of
25% in its levels was observed (p = 0.014) (Figure 1G). Interest-
ingly, the levels of miR-15a were also elevated by 60% in the
plasma of mice subjected to chronic stress (p = 0.047),
whereas the levels of miR-124, an abundant brain miRNA,
were unchanged (Figures S2A and S2B), implicating miR-15a
as a possible marker for chronic stress exposure. These ex-
periments led us to focus on miR-15a and FKBP51 and
address their involvement in mediating chronic stress cellular
processes.
miR-15a Transcription Regulation
miR-15a is located on chromosome 14 as part of a cluster with
miR-16-1 (Figure 2A), indicating that these two miRNAs are co-
transcribed. Previous studies have demonstrated that the pro-
moter for miR-15a and miR-16-1 is likely to be the promoter
for DLEU2, a non-coding gene that contains the transcript
for miR-15a (Zhang et al., 2012). Although both miR-15a
and miR-16-1 share a seed sequence, their mature miRNA
sequence differs in several nucleotides (Figure 2B). In addition,
the total levels of miR-16 in most brain areas appear to be higher
than that of miR-15a (Figure 2C), possibly since miR-16 has two
copies in the genome (miR-16-1 on chromosome 14 and miR-
16-2 on chromosome 3), which both give rise to a similar mature
form of miR-16, whose genomic origin is indistinguishable.
Importantly, the elevation in miR-15a levels observed in our
Ago2 IP is specific for this miRNA and not for miR-16 (Figure 2D),
implying miR-15a specificity at the level of the Ago2 complex
formation.
FKBP51 Is a Confirmed Target of miR-15a
Consistent with direct targeting of FKBP51 by miR-15a,
the seed sequence for miR-15a binding at the 30 UTR of
FKBP51 is highly conserved (Figure 3A). Moreover, a lucif-
erase assay, in which a construct containing luciferase
followed by the 30 UTR of FKBP51 was constructed and trans-
fected into Huh7 cells expressing either miR-15a or a
scramble control for it, showed a robust specific reduction
in normalized luciferase levels (p < 0.001; Figure 3B). Impor-
tantly, this reduction was abolished when the miR-15a seed
Figure 3. FKBP51 Is Regulated by miR-15a In Vitro
(A) Schematic illustration of FKBP51 30 UTR indicating the conserved seed match for miR-15a.
(B) Luciferase assay with luciferase fused to the 30 UTR of FKBP51 containing an intact or a control of a mutated (mut) seed site for miR-15a in the presence of
miR-15a or control scramble miR (n = 6) showed a 50% decrease in luciferase levels, t(10) = 9.083, p = 0.000. This decrease was abolished when the intact
FKBP51 30 UTR contained a miR-15a mutated seed. Data are represented as mean ± SEM. ***p < 0.001sequence was mutated (Figure 3B). These results support a
regulatory role for miR-15a in directly controlling FKBP51
levels.
Overexpression of miR-15a in the Basolateral Amygdala
Does Not Affect Anxiety-like Behavior
To examine whether increased levels of miR-15a in the amyg-
dala are sufficient to mimic the behavioral effects associated
with chronic stress exposure, we designed, constructed, and
produced lentiviruses overexpressing the precursor of miR-
15a or a scramble miR sequence as a control (Figure S3A).
The degree of infection and the levels of miR-15a expression
were verified using qPCR on RNA samples extracted from
amygdala punches obtained from mice injected with these vi-
ruses into the basolateral amygdala (BLA). The treated mice
showed an approximately 2-fold increase in the level of amyg-
dalar miR-15a compared to scramble control (p < 0.001; Fig-
ure S3B), which is similar to the elevated levels of miR-15a
observed following exposure to chronic stress (Figure 1F).
To assess the stress-related behavioral changes of mice ex-
pressing higher levels of miR-15a, mice were injected bilater-
ally into the BLA with either miR-15a-overexpressing or
control-scrambled viruses under basal or chronic stress
conditions (Figures S3C–S3E). Behavioral assessment of the
injected mice indicated no significant changes between mice
overexpressing miR-15a or a control scramble miR in the
open-field test, or in the elevated plus maze (EPM) test, under
baseline (Figures S4A and S4C) or chronic stress (Figures S4B
and S4D) conditions. In addition, no changes were observed in
the locomotor activity or total time traveled in the open field
test of mice overexpressing miR-15a compared to control
scramble miR under basal (Figures S4E–S4G) or chronic
stress conditions (Figures S4H–S4J). Therefore, we concluded
that overexpression of miR-15a in the BLA is not sufficient tomimic the behavioral effects associated with exposure to
chronic social defeat.
Reduced Levels of miR-15a in the BLA Increases
Anxiety-like Behavior following Exposure to Chronic
Stress
Next, we assessed the requirement of endogenous amygdalar
miR-15a levels for the behavioral responses under baseline
and chronic stress conditions. We designed, constructed, and
produced a viral vector containing multiple binding sites for
miR-15a (miR-15a Sponge), which enabled the knockdown
(KD) of miR-15a levels in the BLA (Figure 4A). The control sponge
viral construct was generated by specifically mutating 4 bp on
each side of the bulge of the sponge (Figure 4A). Injection
of the miR-15a KD or control sponge viruses into the BLA of
mice, regardless of their exposure to chronic social defeat, re-
sulted in an approximately 2.5-fold reduction in the levels of
miR-15a in the BLA under basal conditions (p = 0.019) and
following social defeat (p = 0.012) (Figures 4B and 4C). Whereas
a reduction was observed independently of chronic stress, the
absolute levels of miR-15a were higher in the chronic social
defeat group compared to controls (Figure 4C). This supports
our initial observation regarding elevation in miR-15a levels in
the amygdala following chronic social defeat. The BLA of an
additional group of mice was injected with miR-15a sponge
and a control sponge virus (Figure S5A), and RNAwas extracted.
The levels of miR-15awere confirmed to be reduced by 40% (p =
0.009) using real-time PCR (Figure S5B). These samples were
also sequenced using the Illumina TruSeq Small RNA Library
Preparation Kit, and no significant changes were observed in
the 25 most abundant miRNAs (Figure 4D), thus verifying a spe-
cific KD for miR-15a. As expected from our luciferase assay,
FKBP51 mRNA levels were elevated in the BLA of mice injected
with the miR-15a KD virus (p = 0.033; Figure 4E). The proteinCell Reports 17, 1882–1891, November 8, 2016 1885
Figure 4. KD of miR-15a in the BLA Results in Increased FKBP51 Levels in the BLA
(A) Schematic illustration of lentiviral GFP-labeled constructs of control and sponge used to knock down miR-15a.
(B) Representative microscope image of virally infected basolateral amygdala (BLA) of a 10-week-old mouse following injection of lentiviral miR-15a KD with
enlargement of the BLA region that corresponds to the injection site (Paxinos and Franklin, 2001).
(C) Left: decreased miR-15a levels in the BLA (n = 4) of mice injected with miR-15a KD relative to control under basal conditions, t(6) = 3.175, p = 0.019; or (right)
following social defeat, t(6) = 3.528, p = 0.012. Data are represented as mean ± SEM.
(D) miRNA sequencing data. No differences are observed in the top 25 most abundant miRNA from mice injected with miR-15a KD virus compared with the
control virus.
(E) Elevated FKBP51 levels in the BLA (n = 7) of mice injected with miR-15a KD relative to control, t(12) =2.413, p = 0.033. Data are represented asmean ± SEM.
(F and G) FKBP51 protein levels following miR-15a KD virus injection to the BLA. FKBP51 protein levels are upregulated in the BLA of mice injected with miR-15a
KD virus compared with control virus, t(6) = 3.060, p = 0.022. Data are represented as mean ± SEM.
*p < 0.05.
See also Figures S3 and S5.levels of FKBP51 were increased by approximately 50% (p =
0.022; Figures 4F and 4G) following injection of miR-15a KD or
control viruses.
Next, we assessed the miR-15a KD mice for anxiety-like
behavior using the EPM test. Under baseline conditions (in which
mice were not exposed to chronic social defeat), a tendency
toward main effect was observed (p = 0.058). No significant
changes were observed in the time spent in the open arms, num-
ber of visits to the open arms, or distance traveled in the open
arms between the miR-15a KD and control groups (Figures
5A–5C). Similarly, the locomotor activity and the total distance
traveled in the open field test showed no differences between
these groups (Figures 5H–5J). Intriguingly, however, following
chronic social defeat, a main effect between the behavior of
miR-15a KD and control mice was observed (p = 0.026). Mice
with miR-15a KD spent significantly less time in the open arms
(p = 0.009) (Figures 5D and 5G) and traveled less distance in
the open arms relative to controls (p = 0.002; Figures 5F and
5G, (asterisks indicate significance following correction with
Bonferroni correction for multiple testing). No differences were
observed in the number of visits to the open arms, the locomotor
activity between the groups, or the total distance traveled in the1886 Cell Reports 17, 1882–1891, November 8, 2016open field test (Figures 5E and 5K–5M). These results demon-
strate that KD of miR-15a levels in the amygdala specifically
impaired the recovery and behavioral response of mice following
their exposure to chronic stress. In the open field test, miR-15a
KD mice spent less time in the center of the arena (p = 0.032),
but no changes were observed in the distance traveled in the
center or the number of visits to the center (Figure S5C).
Following chronic social defeat, miR-15a KD and control mice
spent similarly less time in the center of the arena, suggesting
a ‘‘floor effect.’’ However, miR-15a KD mice showed a tendency
to travel for less distance in the center of the arena (p = 0.060)
and made fewer visits to the center of the arena (p = 0.041) (Fig-
ure S5D). These results are in accordance with Hartmann
et al. (2015), who observed induced anxiety-related behavior
following overexpression of FKBP51 in the BLA. Moreover, Att-
wood et al. (2011) showed that silencing of FKBP51 levels in
the BLA by injection of lentiviral short hairpin RNA led to a reduc-
tion in anxiety levels in the EPM. Taken together, the present data
suggest that amygdalar miR-15a levels are functionally impor-
tant in regulating the behavioral response to challenge and
suggest that this effect is mediated, at least in part, via a
reduction of FKBP51 levels.
(legend on next page)
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miR-15a Is Regulated by Glucocorticoids and Trauma in
Human Samples
To examine the potential parallel role of miR-15a in the human
stress response, we first analyzed miR-15a expression levels
in RNA extracted from peripheral blood cells of young healthy
male subjects following administration of the glucocorticoid re-
ceptor (GR) agonist dexamethasone (1.5 mg orally [p.o.]). We
observed a significant upregulation of miR-15a at 3 and 6 hr
post-treatment (Figure 6A), indicating that miR-15a is potentially
regulated by activation of the stress hormone system in humans.
In addition, we performed miRNA analyses on peripheral blood
cells of subjects with childhood trauma and control subjects
matched for age and gender with no history of early life stress.
We found that the levels of miR-15a were significantly higher
by 32% in subjects exposed to childhood trauma as compared
to control subjects who were not exposed (p = 0.000, Figure 6B).
Taken together, these results support a functional associ-
ation between the blood levels of miR-15a and psychiatric
impairment.
DISCUSSION
The present study reveals an important role for amyg-
dalar miR-15a in regulating the behavioral responses to
chronic stressful challenges. miR-15a levels are significantly
increased in the amygdala of mice subjected to chronic
stress, and amygdala-specific KD of miR-15a changes the
behavioral responses to chronic stressful challenges. A target
of miR-15a, FKBP51, identified in our studies, has been impli-
cated in a number of stress-related psychiatric disorders
(Binder, 2009; Zannas et al., 2016). FKBP51 is part of the im-
munophilin protein family and is known to play a role in GR
transcriptional activation following the elevation of cortisol
(Gillespie et al., 2009). Manipulation of FKBP51 levels in the
BLA, using small interfering RNA (Attwood et al., 2011), or of
its overexpression, using a viral vector (Hartmann et al.,
2015), has been linked to changes in anxiety-like behavior.
FKBP51, which is strongly implicated in a number of stress-
related psychiatric disorders and is currently a leading target
for pharmacological manipulation for the treatment of various
psychopathologies, is robustly regulated both in vitro and
in vivo by miR-15a. Importantly, miR-15a is upregulated by
pharmacological activation of the stress response in humans
by dexamethasone treatment, as well as exposure to early
adverse life events. Therefore, miR-15a might representFigure 5. Mice with Virally Mediated Reduced Levels of BLA-miR-15a
(A–C) Results from the elevated plus maze (EPM) test of mice injected with miR-1
differences, F(3, 19) = 2.971, p = 0.058. No significant differences were observed in
the distance traveled in the open arms (C), according to Bonferroni correction fo
(D–F) Mice injected with miR-15a KD or control viruses (ns = 10 and 9, respectiv
EPM, F(3, 15) = 4.08, p = 0.026; with a significant decrease in the time (D) (U = 13,
(corrected according to Bonferroni correction formultiple testing). No changeswe
mean ± SEM.
(G) Representative tracking in the EPM of control mice (upper panel) relative to m
(H–M) No changes were observed in the locomotor activity and total distance tra
conditions (H–J) or following social defeat (K–M). Data in (I)–(J), (L), and (M) are r
*p < 0.05; **p < 0.01.
See also Figures S4 and S5.
1888 Cell Reports 17, 1882–1891, November 8, 2016an important target for the treatment of stress-related
psychopathologies.
Our results imply that, in the chronic stress response, miR-15a
and its target FKBP51 represent major components for the
following reasons: Although miR-15a is bioinformatically pre-
dicted to target other stress- and depression/anxiety-related
transcripts, such as GILZ or Sgk1 (Anacker et al., 2013; Thiagar-
ajah et al., 2014), the mRNA levels of these genes were un-
changed in our Ago2 IP array (data not shown), supporting the
specificity of the assay. In the present study, we focused exclu-
sively on miR-15a regulation of FKBP51 due to the reported
involvement of this gene in stress-response regulation and
stress-linked psychopathologies (Hartmann et al., 2012, 2015;
Scharf et al., 2011). Furthermore, FKBP51 mRNA was detected
in the Ago2 complex, implicating a direct binding to the RNAima-
chinery. Finally, a significant decrease in FKBP51 levels was
observed in the total RNA samples that concomitantly exhibited
elevated miR-15a levels. Nevertheless, it is important to note
that FKBP51 is not the only predicted target of miR-15a and
that the changes observed in anxiety-like behavior after knock-
ing down the levels of miR-15a in vivo are not mediated merely
by affecting the levels of FKBP51.
Although BLA-specific overexpression of miR-15a resulted in
no significant behavioral changes, knocking down miR-15a in
the BLA caused an anxiogenic phenotype following exposure
to chronic stress. The regulation of miR-15a following exposure
to chronic stress and the observed anxiogenic phenotype in the
BLA-miR-15a KD mice following chronic stress exposure may
suggest that miR-15a is specifically involved in regulating the
behavioral responses to repeated or chronic stressful exposure.
Nevertheless, miR-15amay potentially be important also in regu-
lating anxiety levels, regardless of the stress history of the mice,
and its effectmay be amplified by stress. The lack of an anxiolytic
phenotype in the BLA-miR-15a-overexpressing mice could be
explained either by lack of spatial specificity, meaning that the
overexpression of miR-15a was not induced in endogenously
relevant BLA neurons, or by a possible ‘‘ceiling effect,’’ in which
increasing levels of miR-15a on top of its endogenous stress-
induced elevation is not effective because the stress response
has already reached its full capacity. However, preventing the
elevation of endogenous miR-15a in the BLA by its KD resulted
in a failure of themice tomount the required behavioral response
when exposed to a chronic stressful challenge.
Finally, the elevation of miR-15a in two distinct human stress-
linked scenarios—namely, administration of dexamethasoneExhibit Increased Anxiety-like Behavior
5a KD or control viruses (ns = 11 and 12, respectively) showing a tendency for
the time spent in the open arms (A), the number of visits to the open arms (B), or
r multiple testing. Data are represented as mean ± SEM.
ely) that were also subjected to social defeat showed different behavior in the
p = 0.009) and distance (F) (U = 7, p = 0.002) spent in the open arms of the EPM
re observed in the number of visits to the open arms (E). Data are represented as
iR-15a KD mice (lower panel).
veled in the open field test between miR-15a KD and control mice under basal
epresented as mean ± SEM.
Figure 6. miR-15a Level in Human Periph-
eral Blood Is Higher following Acute Dexa-
methasone Treatment and Exposure to
Childhood Trauma
(A) Relative miR-15a levels in peripheral blood cells
of young healthy male subjects following 1.5 mg
dexamethasone treatment. Repeated-measures
ANOVA: F(4, 22) = 4.42, p = 0.009. *p < 0.05; **p <
0.01. A significant upregulation of miR-15a was
observed 3 hr post-treatment, t(25) = 2.240, p =
0.034; and 6 hr post-treatment, t(25) = 3.487, p =
0.002.
(B) Levels of miR-15a in blood of subjects exposed
to childhood trauma as compared to subjects not
exposed, t(29.715) = 13.776, p = 0.000. Data are
represented as mean ± SEM.to healthy subjects as well as individuals exposed to
childhood trauma—strongly suggests its involvement in hu-
man stress conditions. Collectively, the preclinical and
human translational results presented in the present study
strongly suggest that alterations in miR-15a levels are
associated with the behavioral response to chronic or
repeated stressful challenges and may be relevant in the
pathogenesis of adverse life events and stress-linked psy-
chiatric disorders such as anxiety. Targeting miR-15a levels
might prove to be beneficial in the treatment of these
conditions.
EXPERIMENTAL PROCEDURES
See also the Supplemental Experimental Procedures.
Chronic Social Defeat Stress
10-week old C57BL/6J male mice were subjected to a chronic social
defeat stress protocol, as previously described (Krishnan et al., 2007). Briefly,
the mice were placed randomly in a home cage of an aggressive ICR
mouse and allowed to physically interact for 5 min. During this time, the ICR
mouse attacked the intruder mouse and the intruder displayed subordinate
posturing. A perforated clear Plexiglas divider was then placed between
the animals, and they remained in the same cage for 24 hr to allow sensory
contact. The procedure was then repeated with an unfamiliar ICR mouse for
each of the next 10 days. The animal protocols were approved by the Institu-
tional Animal Care and Use Committee (IACCU) of the Weizmann Institute of
Science.
IP of Ago2 Protein, RNA Purification, and Microarray
Pools of three amygdalae taken from three mice from the same treatment
group (either social defeat, n = 18, or control, n = 12) were immunoprecipitated
using magnetic protein G beads (Dynabeads, Invitrogen/Life Technologies)
and Ago2 monoclonal antibody (WAKO Chemicals).
RNA from the Ago2 IP samples was isolated and analyzed on an Affymetrix
miRNA 2.0 array (enriched RNA protocol) and an Affymetrix Mouse Gene 1.0
ST array .
Cloning of 30 UTRs into Psicheck2 Luciferase Expression Plasmid
The 30 UTR sequence of FKBP51 was PCR amplified from mouse genomic
DNA. This mutation replaced the first 4 nt in the miR-15a seed sequence of
FKBP51.
Design, Construction, and Validation of miR-15a Lentiviruses
The miR-15a overexpression vector was cloned following the human synapsin
promoter. The miR scramble control was purchased from GeneCopoeia. The
H1-miR-15a sponge KD and its control were designed according to Lin et al.
(2011).Stereotactic Intracranial Injections
A computer-guided stereotaxic instrument and a motorized nanoinjector
(Angle Two Stereotaxic Instrument, myNeuroLab, Leica Biosystems) were
used as described previously (Elliott et al., 2010; Kuperman et al., 2010; Regev
et al., 2012).
Behavioral Assessments
All behavioral assessments were performed during the dark (active) phase
following habituation to the test room for 2 hr before each test.
Open-Field Test
The open-field test was performed in a 50 3 50 3 22-cm white box, lit to 120
lux. The mice were placed in the box for 10 min. Locomotion in the box was
quantified using a video tracking system (VideoMot2; TSE Systems).
EPM Test
The apparatus in this test is designed as a plus sign and contains two barrier
walls and two open arms. During the 5-min test, which is performed in relative
darkness (6 lux), data are scored using a video tracking system (VideoMot2,
TSE Systems).
Homecage Locomotion
Homecage locomotion was assessed using the InfraMot system (TSE Sys-
tems). Measurements of general locomotion consisted of two light and two
dark cycles in the last 48 hr, collected at 10-min intervals.
Statistics
Data are expressed as mean ± SEM and were performed using the Statistical
Package for the Social Sciences (SPSS) software.
Human Studies: Dexamethasone
Dexamethasone-unstimulated peripheral blood samples were drawn at 12:00
p.m. followed by oral administration of 1.5 mg dexamethasone. Subsequently,
stimulated samples were collected at 1:00 p.m., 3:00 p.m., 6:00 p.m., and at
11:00 a.m. the following day.
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